Home | Welcome to Contract Pharma   
Last Updated Tuesday, June 2 2015

Print

Search Results for 'Industry News'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published June 2, 2015
Expands its CDMO capabilities Read More »
Published June 2, 2015
Sales of acquired brands were approximately $110 million in 2014 Read More »
Published June 1, 2015
Expands program leveraging companies’ investment in R&D Read More »
Published June 1, 2015
Outsourced design and development services has proven to be important to the company’s customer base Read More »
Published May 27, 2015
To explore late-stage assets in combination with Imbruvica Read More »
Published May 22, 2015
Expands protein detection franchise Read More »
Published May 22, 2015
To provide aseptic and low bioburden clean room dispensing of bulk materials Read More »
Published May 21, 2015
Acquires exclusive worldwide rights to SMC technology for research applications Read More »
Published May 20, 2015
Hospira to pair LISA TRACKER with its Remicade biosimilar Read More »
Published May 20, 2015
GEA Niro Mobile Minor enhances solutions for poorly soluble compounds Read More »
Published May 19, 2015
Bolsters liquid generics portfolio Read More »
Published May 19, 2015
Will offer complete portfolio of solutions and services Read More »
Published May 19, 2015
Strategically expanding generics business to a top five industry leader Read More »
Published May 18, 2015
Increases funds for R&D efforts for Structured Organic Particulate Systems Read More »
Published May 18, 2015
Will continue to supply Sodium Chloride Injection to alleviate drug shortage Read More »
Published May 15, 2015
Marks the first approved combination and sumatriptan migraine product for patients 12-17 Read More »
Published May 14, 2015
Catalent to provide biomanufacturing activities for MANF protein Read More »
Published May 13, 2015
Launched as part of a global distribution agreement with CytoMate Technologies BV Read More »
Published May 13, 2015
Part of the CRO's globalization strategy Read More »
Published May 13, 2015
Offers improved compaction properties in direct compression applications Read More »
Published May 13, 2015
Will deploy inspection and quality control solutions; framework established for co-development projects Read More »
Published May 12, 2015
Will support commercial-scale ADC manufacturing Read More »
Published May 12, 2015
To bolster clinical and commercial bulk drug production and fill/finish for gene therapies Read More »
Published May 12, 2015
Secures exclusive option to acquire the company following a Phase II trial of recAP Read More »
Published May 12, 2015
Gains softgel manufacturing technology Read More »
Published May 12, 2015
To open new R&D centers in Asia Pacific and in Europe Read More »
Published May 12, 2015
Gains leading biologic treatment and oncology infrastructure for $900M Read More »
Published May 11, 2015
Adds approximately 60 on-market products and nearly 70 R&D pipeline programs Read More »
Published May 11, 2015
The acquired business produces active pharmaceutical ingredients and intermediate products Read More »
Published May 8, 2015
Additional 27,000 sq.-ft. will supply materials for clinical trials Read More »
Published May 8, 2015
Derek Hennecke selected from more than 70 nominations Read More »
Published May 7, 2015
Recognized for dedicated capacity to grow Read More »
Published May 7, 2015
Finalizes ISO 9001 and ISO 5001 Certification Read More »
Published May 6, 2015
Expects revenues from device-enabled products to double by 2020 Read More »
Published May 6, 2015
Gains portfolio of histone demethylases for the treatment of certain cancers Read More »
Published May 5, 2015
Will assume clinical development and commercialization of ISIS-FXIRx Read More »
Published May 5, 2015
To add commercial spray-drying capacity for inhalation technologies to treat
a wider range of diseases Read More »
Published April 27, 2015
U.S. license rights to Nucynta family of products sold to Depomed Read More »
Published April 27, 2015
Celgene committed to expanding sustainable pipeline of cancer treatments Read More »
Published April 24, 2015
Multi-purpose facility is among the largest bulk API manufacturing facilities for recombinant microbial biologics Read More »
Published April 23, 2015
Dako completes corrective actions following Warning Letter Read More »
Published April 22, 2015
Combination would create an industry giant in the global generics space Read More »
Published April 22, 2015
Expands advanced, aseptic, glass-free injectable platform Read More »
Published April 22, 2015
Lab has more than doubled in size and will serves as a cGMP testing site Read More »
Published April 21, 2015
Will evaluate Zydis Technology to develop thermo stable and cold-chain independent vaccines Read More »
Published April 20, 2015
Provides clients with broad range of standardized lab testing services and capabilities Read More »
Published April 20, 2015
New technical center, cGMP distribution center and headquarters enhances ability to support customers in the region Read More »
Published April 17, 2015
Samcyprone used for the treatment of malignant melanoma stage IIb to IV Read More »
Published April 17, 2015
Accelerates development of a leading North American dermatology company Read More »
Published April 17, 2015
Takeover expands Sartorius’ service portfolio Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On